Microbiology and risk factors for central line-associated bloodstream infections among pediatric oncology outpatients: A single institution experience of 41 cases

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 2, 2013, Pages

  Kelly, Matthew S ^a   Conway, Margaret ^a   Wirth, Kathleen E ^c   Potter Bynoe, Gail ^a   Billett, Amy L ^a   Sandora, Thomas J ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

catheter infections; communityonset CLABSI; neutropenia; pediatric oncology

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; DACTINOMYCIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW SUPPRESSION; CASE CONTROL STUDY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; HOSPITALIZATION; HUMAN; INFECTION RISK; LYMPHOBLASTOMA; MALE; MICROBIOLOGY; NEUTROPENIA; NEUTROPHIL COUNT; OUTPATIENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; STEM CELL TRANSPLANTATION;

EID: 84874477669     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182820edd     Document Type: Article

References (30)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics 2012. CA Cancer J Clin. 2012;62:10-29.
2. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for disease control and prevention. MMWR Recomm Rep. 2002;51(RR-10):1-29.
3. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271:1598-1601.
4. Biwersi C, Hepping N, Bode U, et al. Bloodstream infections in a German paediatric oncology unit: prolongation of inpatient treatment and additional costs. Int J Hyg Environ Health. 2009;212:541-546.
5. Siempos II, Kopterides P, Tsangaris I, et al. Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis. Crit Care Med. 2009;37: 2283-2289.
6. Kallen AJ, Patel PR, O'Grady NP. Preventing catheter-related bloodstream infections outside the intensive care unit: expanding prevention to new settings. Clin Infect Dis. 2010;51:335-341.
7. Allen CR, Holdsworth MT, Johnson CA, et al. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer. 2008;51:53-58.
8. Safer M. Preventing infections in outpatient and home health care settings. July 2012. Available at: http://www.childrens hospitals.net/AM/ Template.cfm?Section = Hematology-oncology &CONTENTID = 63036&TEMPLATE = /CM/ContentDisplay. cfm. Accessed October 5, 2012.
9. The Joint Commission. National Patient Safety Goals Effective January 1, 2012: Hospital Accreditation Program, NPSG.07.04.01. Available at: http://www.jointcommission.org/assets/1/6/NPSG-Chapter-Jan2012-HAP.pdf. Accessed February 5, 2012.
10. US Department of Health and Human Services. HHS action plan to prevent healthcare-associated infections. Available at: http://www.hhs.gov/ash/ initiatives/hai/nationaltargets/index.html. Accessed February 5, 2012.
11. Center for Disease Control and Prevention. Basic infection control and prevention plan for outpatient oncology settings. Available at: http://www.cdc.gov/hicpac/pdf/guidelines/basic-infection-control-prevention- plan-2011.pdf. Accessed February 6, 2012.
12. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med. 2004;32:2014-2020.
13. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355:2725-2732.
14. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-332.
15. Kelly M, Conway M, Wirth K, et al. Moving CLABSI prevention beyond the ICU: risk factors in pediatric oncology patients. Infect Control Hosp Epidemiol. 2011;32:1079-1085.
16. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for disease control and prevention 2000 growth charts for the united states: improvements to the 1977 national center for health statistics version. Pediatrics. 2002;109:45-60.
17. Adler A, Yaniv I, Steinberg R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect. 2006;62: 358-365.
18. Ross MN, Haase GM, Poole MA, et al. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients. Surg Gynecol Obstet. 1988;167:141-144.
19. Sitges-Serra A, Linares J, Perez JL, et al. Randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. Parenter Enteral Nutr. 1985;9:322-325.
20. Linares J, Sitges-Serra A, Garau J, et al. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol. 1985;21:357-360.
21. Raad I, Costerton W, Sabharwal U, et al. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993;168:400-407.
22. Wurzel CL, Halom K, Feldman JG, et al. Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child. 1988;142:536-540.
23. Simon A, Ammann RA, Bode U, et al. Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis. 2008;8:70.
24. Stamou SC, Maltezou HC, Pourtsidis A, et al. Hickman-Broviac catheter-related infections in children with malignancies. Mt Sinai J Med. 1999;66:320-326.
25. Viscoli C, Castagnola E, Giacchino M, et al. Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian association of paediatric haematology and oncology. Eur J Cancer. 1999;35:770-774.
26. Shah SS, Manning ML, Leahy E, et al. Central venous catheter-associated bloodstream infections in pediatric oncology home care. Infect Control Hosp Epidemiol. 2002;23:99-101.
27. Smith TL, Pullen GT, Crouse V, et al. Bloodstream infections in pediatric oncology outpatients: a new healthcare systems challenge. Infect Control Hosp Epidemiol. 2002;23:239-243.
28. Toscano CM, Bell M, Zukerman C, et al. Gram-negative bloodstream infections in hematopoietic stem cell transplant patients: the roles of needleless device use, bathing practices, and catheter care. Am J Infect Control. 2009;37:327-334.
29. Sexton DJ, Chen LF, Anderson DJ. Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes? Infect Control Hosp Epidemiol. 2010;31:1286-1289.
30. Shuman EK, Washer LL, Arndt JL, et al. Analysis of central line-associated bloodstream infections in the intensive care unit after implementation of central line bundles. Infect Control Hosp Epidemiol. 2010;31:551-553.